Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: Diagnostic value and relationship to disease severity and outcome

被引:67
作者
Simmons, CP
Thwaites, GE
Quyen, NTH
Torok, E
Hoang, DM
Chau, TTH
Mai, PP
Lan, NTN
Dung, NH
Quy, HT
Bang, ND
Hien, TT
Farrar, J
机构
[1] Hosp Trop Dis, Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam
[2] Pham Ngoc Thach Hosp TB & Lung Dis, Ho Chi Minh City, Vietnam
关键词
D O I
10.4049/jimmunol.176.3.2007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tuberculous meningitis (TBM) is the most devastating form of tuberculosis. Both intracerebral and peripheral blood immune responses may be relevant to pathogenesis, diagnosis, and outcome. In this study, the relationship between pretreatment host response, disease phenotype, and outcome in Vietnamese adults with TBM was examined. Before treatment, peripheral blood IFN-gamma ELISPOT responses to the Mycobacterium tuberculosis Ags ESAT-6, CFP-10, and purified protein derivative (PPD) were a poor diagnostic predictor of TBM. Cerebrospinal fluid IL-6 concentrations at presentation were independently associated with severe disease presentation, suggesting an immunological correlate of neurological damage before treatment. Surprisingly however, elevated cerebrospinal fluid inflammatory cytokines were not associated with death or disability in HIV-negative TBM patients at presentation. HIV coinfection attenuated multiple cerebrospinal fluid inflammatory indices. Low cerebrospinal fluid IFN-gamma concentrations were independently associated with death in HIV-positive TBM patients, implying that IFN-gamma contributes to immunity and survival. Collectively, these results reveal the effect of HIV coinfection on the pathogenesis of TBM and suggest that intracerebral immune responses, at least in HIV-negative cases, may not be as intimately associated with disease outcome as previously thought.
引用
收藏
页码:2007 / 2014
页数:8
相关论文
共 32 条
[1]   CEREBROSPINAL-FLUID INTERLEUKIN-1-BETA INTERLEUKIN-1 RECEPTOR ANTAGONIST BALANCE AND TUMOR-NECROSIS-FACTOR-ALPHA CONCENTRATIONS IN TUBERCULOUS, VIRAL AND ACUTE BACTERIAL-MENINGITIS [J].
AKALIN, H ;
AKDIS, AC ;
MISTIK, R ;
HELVACI, S ;
KILICTURGAY, K .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1994, 26 (06) :667-674
[2]   Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens [J].
Brodin, P ;
Majlessi, L ;
Brosch, R ;
Smith, D ;
Bancroft, G ;
Clark, S ;
Williams, A ;
Leclerc, C ;
Cole, ST .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (01) :115-122
[3]   ESAT-6 proteins: protective antigens and virulence factors? [J].
Brodin, P ;
Rosenkrands, I ;
Andersen, P ;
Cole, ST ;
Brosch, R .
TRENDS IN MICROBIOLOGY, 2004, 12 (11) :500-508
[4]   Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol [J].
Condos, R ;
Rom, WN ;
Schluger, NW .
LANCET, 1997, 349 (9064) :1513-1515
[5]   CONCENTRATIONS OF INTERFERON-GAMMA, TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA IN THE CEREBROSPINAL-FLUID OF CHILDREN TREATED FOR TUBERCULOUS MENINGITIS [J].
DONALD, PR ;
SCHOEMAN, JF ;
BEYERS, N ;
NEL, ED ;
CARLINI, SM ;
OLSEN, KD ;
MCCRACKEN, GH .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (04) :924-929
[6]   Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak [J].
Ewer, K ;
Deeks, J ;
Alvarez, L ;
Bryant, S ;
Waller, S ;
Andersen, P ;
Monk, P ;
Lalvani, A .
LANCET, 2003, 361 (9364) :1168-1173
[7]   AN ESSENTIAL ROLE FOR INTERFERON-GAMMA IN RESISTANCE TO MYCOBACTERIUM-TUBERCULOSIS INFECTION [J].
FLYNN, JL ;
CHAN, J ;
TRIEBOLD, KJ ;
DALTON, DK ;
STEWART, TA ;
BLOOM, BR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2249-2254
[8]   Immunology of tuberculosis [J].
Flynn, JL ;
Chan, J .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :93-129
[9]   Tuberculosis of the central nervous system [J].
Garg, RK .
POSTGRADUATE MEDICAL JOURNAL, 1999, 75 (881) :133-140
[10]  
GUY E, 2005, J INFECT DIS, V192, P2134